Sanoria, Florencio G.
HRN: 27-98-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/23/2025
10/30/2025
IV
500mg
Q8h
Intraabdominal Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes